Last mentioned: Mar 4, 2026
Target Birth Date
Projected window for the birth of the first mammoth-elephant hybrid calf.
Dubai Biovault
Colossal announces the opening of a major genetic preservation facility in Dubai.
Series B Funding
Total funding surpasses $225M, valuing the company at over $1 billion.
Dodo Project Announced
The company expands its portfolio to include the de-extinction of the dodo bird.
Company Launch
Colossal Biosciences officially launches with $15M in seed funding to revive the woolly mammoth.
Colossal Biosciences is advancing its mission to revive the woolly mammoth by 2028, sparking intense debate over the ethics of de-extinction. While the startup has secured over $225 million in venture capital, critics argue the project is a costly distraction from urgent conservation efforts for living species.
Colossal Biosciences is advancing its ambitious plan to 'de-extinct' the woolly mammoth using CRISPR technology, sparking intense debate over ecological ethics and resource allocation. While the company frames the project as a climate solution, critics argue it distracts from urgent conservation efforts for existing endangered species.